The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Amarin disavows any obligation to update the information contained in such press releases after the date of their issuance.
DUBLIN and MYSTIC, Conn., May 12 /PRNewswire-FirstCall/ -- Amarin Corporation plc (Nasdaq:AMRN News) has scheduled a conference call for Thursday, May 13, 2010 at 4:00 p.m. GMT (11:00 a.m. Eastern Time) to discuss selected financial results and provided a progress update of the Company's ANCHOR and
Dublin, Ireland and Mystic, CT, USA , April 27, 2010 – Amarin Corporation plc (NASDAQ: AMRN) today announced that John Thero, Chief Financial Officer, is scheduled to present at Deutsche Bank Securities 35th Annual Health Care Conference.The presentation will be made on Monday, May 3, 2010 at 2:50
DUBLIN and MYSTIC, Conn., March 3 /PRNewswire-FirstCall/ --Amarin Corporation plc (Nasdaq: AMRN - News ) today announced that John F. Thero, Chief Financial Officer, is scheduled to present at Cowen and Company's 30th Annual Healthcare Conference on Wednesday, March 10, 2010 at 8:45 am Eastern
DUBLIN and MYSTIC, Conn, Feb. 11 -- Amarin Corporation plc (Nasdaq: AMRN), a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, is pleased to announce the appointment of Mr. Jan van Heek to its board of directors as a non-executive director.
DUBLIN and MYSTIC, Conn., Feb. 2 /PRNewswire-FirstCall/ -- Amarin Corporation plc (Nasdaq: AMRN ) today announced that Dr. Declan Doogan, Interim Chief Executive Officer, is scheduled to present at the 12th Annual BIO CEO & Investor Conference on Monday, February 8th at 10:30am Eastern Time.
DUBLIN, Ireland, November 23, 2009 – Amarin Corporation plc (NASDAQ: AMRN) announced today that it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on December 21, 2009 in Dublin, Ireland. Copies of the Notice, together with the Company’s Annual